静脉对乙酰氨基酚不能减少急诊科患者缓解疼痛的吗啡用量:一项多中心、随机、双盲、安慰剂对照试验
本研究为多中心、随机、双盲、安慰剂对照试验,纳入年龄>18岁、急性疼痛(NRS>4)的急诊患者,排除6小时内已用镇痛药、慢性疼痛或临床不稳定者。患者按1:1随机接受吗啡0.1 mg/kg联合对乙酰氨基酚1 g静脉注射或吗啡0.1 mg/kg联合安慰剂静脉注射,必要时每15分钟追加吗啡0.05 mg/kg静脉注射直至疼痛缓解(NRS<4)。共随机220例,202例纳入主要结局分析;缓解疼痛所需平均吗啡剂量两组相似(对乙酰氨基酚组0.15±0.07 mg/kg,安慰剂组0.16±0.07 mg/kg),总吗啡量、疼痛缓解时间及不良事件频率(总体27.4%)均无差异;疼痛复发时间风险比1.23(95%CI 0.76-1.98),p=0.40。结论:在首次给予吗啡时,对乙酰氨基酚对疼痛控制或节省吗啡无额外效果;所用滴定吗啡方案高度有效,80%的患者在开始治疗后60分钟内报告疼痛缓解。
要点
- 急诊急性疼痛(NRS>4)患者首剂吗啡时加用静脉对乙酰氨基酚1 g,缓解疼痛所需平均吗啡剂量与安慰剂相似(0.15±0.07 mg/kg vs 0.16±0.07 mg/kg)。
- 总吗啡用量两组无差异(对乙酰氨基酚组0.19±0.09 mg/kg,安慰剂组0.19±0.1 mg/kg)。
- 疼痛缓解时间两组均为30分钟(对乙酰氨基酚组95%CI 17-31分钟,安慰剂组95%CI 30-35分钟),不良事件总体发生率27.4%。
- 疼痛复发时间两组无显著差异(HR 1.23,95%CI 0.76-1.98,p=0.40)。
- 按方案每15分钟追加吗啡0.05 mg/kg静脉注射滴定,80%的患者在开始治疗后60分钟内报告疼痛缓解。
适用人群与场景
- 急诊科年龄>18岁、急性疼痛且数字评定量表(NRS)>4的患者。
- 排除过去6小时内已接受镇痛、慢性疼痛或临床不稳定的患者。
诊断标准与关键阈值
- 急性疼痛定义为数字评定量表(NRS)>4。
- 疼痛缓解定义为NRS<4。
处置流程与药物剂量
- 随机接受吗啡0.1 mg/kg联合对乙酰氨基酚1 g静脉注射,或吗啡0.1 mg/kg联合安慰剂静脉注射。
- 每15分钟追加吗啡0.05 mg/kg静脉注射,直至疼痛缓解(NRS<4),并根据疼痛是否复发决定是否继续追加。
研究设计与关键结果
- 多中心、随机、双盲、安慰剂对照试验;共随机220例,202例纳入主要结局分析。
- 主要结局缓解疼痛所需平均吗啡剂量:对乙酰氨基酚组0.15±0.07 mg/kg,安慰剂组0.16±0.07 mg/kg,两组相似。
- 总吗啡用量:对乙酰氨基酚组0.19±0.09 mg/kg,安慰剂组0.19±0.1 mg/kg,无差异。
- 疼痛缓解时间:对乙酰氨基酚组30分钟(95%CI 17-31分钟),安慰剂组30分钟(95%CI 30-35分钟),无差异。
- 不良事件总体频率27.4%。
- 疼痛复发时间:风险比1.23(95%CI 0.76-1.98),p=0.40,两组无显著差异。
- 80%的患者在开始治疗后60分钟内报告疼痛缓解。
证据类型、等级与局限
- 证据类型:多中心、随机、双盲、安慰剂对照试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在急诊患者首次给予吗啡时,对乙酰氨基酚对疼痛控制或节省吗啡无额外效果。
- 作者指出,所用滴定吗啡方案高度有效,80%的患者在开始治疗后60分钟内报告疼痛缓解。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Pain is one of the main reasons to present to emergency departments (EDs). Opioids are indispensable for acute pain management but are associated with side effects, misuse, and dependence. The aim of this study was to test whether a single dose of intravenous (IV) acetaminophen (paracetamol) can reduce the use of morphine for pain relief and/or morphine-related adverse events (AEs).
METHODS: ED patients >18 years with acute pain (i.e., Numeric Rating Scale [NRS] > 4) were screened for eligibility. Patients with analgesia in the past 6 h, chronic pain, or clinical instability were excluded. Patients were randomized in a 1:1 ratio to receive either morphine 0.1 mg/kg and 1 g acetaminophen IV or morphine 0.1 mg/kg and placebo IV. The intervention was double-blinded. Additional morphine 0.05 mg/kg IV was administered every 15 minutes until pain relief (defined as NRS < 4) and whether the pain recurred. The primary outcome was the mean morphine dose for pain relief. Secondary outcomes were the total amount of morphine given, time to achieve pain relief, and AEs.
RESULTS: A total of 220 patients were randomized and 202 evaluated for the primary outcome. The mean morphine dose for pain relief was similar in both groups (acetaminophen 0.15 mg ± 0.07 mg/kg, placebo 0.16 ± 0.07 mg/kg). There were no differences in the total amount of morphine given (acetaminophen 0.19 ± 0.09 mg/kg, placebo 0.19 ± 0.1 mg/kg), the time to achieve pain relief (acetaminophen 30 min [95% CI 17-31 min], placebo 30 min [95% CI 30-35 min]), and the frequency of AEs (overall 27.4%). Time to pain recurrence did not differ significantly between the groups (hazard ratio 1.23 [0.76-1.98], p = 0.40).
CONCLUSIONS: In ED patients, acetaminophen had no additional effect on pain control or morphine-sparing effect at the time of first morphine administration. Titrated morphine with the algorithm used was highly effective, with 80% of all patients reporting pain relief within 60 min of starting therapy.
参考来源
- Minotti B, Mansella G, Sieber R, et al. Intravenous acetaminophen does not reduce morphine use for pain relief in emergency department patients: A multicenter, randomized, double-blind, placebo-controlled trial. Acad Emerg Med. 2022. PMID: 35491963. doi:10.1111/acem.14517
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。